medigraphic.com
ISSN 1561-3038 (Print)

2022, Number 2

<< Back Next >>

Rev Cubana Med Gen Integr 2022; 38 (2)

Prenatal ultrasound diagnosis at the Genetics Center of Marianao Municipality, Havana

Abadal BGV, Valdivia ÁI

Language: Spanish
References: 26
Page:
PDF size: 816.09 Kb.


ABSTRACT

Introduction: Prenatal ultrasound in the Genetic Disease Prevention Program allows early detection of congenital malformations and improves the quality of life of the mother and her family.
Objective: To know the frequency of congenital malformations diagnosed at the Genetics Center of Marianao Municipality, Havana, Cuba, and to compare it with national and international statistics.
Methods: Retrospective, descriptive and observational study. A total of 203 malformations diagnosed between 2007 and 2017 at the Genetics Center of Marianao were quantified. Maternal age, gestational age at diagnosis, frequency by years and types of malformations by systems were considered as variables.
Results: In 13,307 births, 203 malformed fetuses were diagnosed (1.52 %), at a mean gestational age of 20.15 weeks. The most frequent malformations were neurological (27.1 %) and cardiovascular (16.2 %). Cardiovascular (27.3 %) and digestive (16.2 %) malformations predominated in adolescent mothers, while chromosomal malformations predominated in older mothers (57.1 %). Before the seventeenth week, digestive (41.7 %) and neurological (40 %) malformations were diagnosed; between the eighteenth and twenty-first weeks, skeletal (41.2 %) malformations were diagnosed; between the twenty-second and twenty-sixth weeks, cardiovascular (66.7 %) and chromosomal (52.4 %) malformations were diagnosed; and after the twenty-seventh week, renal (9 %) malformations were diagnosed.
Conclusion: Neurological and cardiovascular malformations prevailed. The mean maternal age was higher in chromosomal malformations, and lower in digestive and cardiovascular malformations. Most of the digestive and neurological malformations were diagnosed in the first marker of the Program, while cardiovascular, chromosomal and skeletal malformations were diagnosed in the second marker.


REFERENCES

  1. Organización Mundial de la Salud. Anomalías congénitas. Nota descriptiva No. 370. 2015 [acceso: 13/03/2018] Disponible en: http://www.who.int/es/news-room/fact-sheets/detail/congenital-anomalies1.

  2. Kamla I, Kamgaing N, Billong S, Noutakdie Tochie J, Tolefac P, de Paul Djientcheu V. Antenatal and postnatal diagnoses of visible congenital malformations in a sub-Saharan African setting: a prospective multicenter cohort study. BMC Pediatrics. 2019;19:457. DOI: https://doi.org/10.1186/s12887-019-1831-x2.

  3. Juárez García L, López Rioja MJ, Leis Márquez MT, Machuca Vaca A, Erdmenger Orellana J. Enfermedad adenomatoidea quística pulmonar, diagnóstico y manejo intrauterino. Reporte de un caso y revisión bibliográfica. Ginecol Obstet México. 2015 [acceso: 13/03/2018];83:320-7 Disponible en: http://www.medigraphic.com/pdfs/ginobsmex/gom-2015/gom155i.pdf3.

  4. Molina Giraldo S, Alfonso Ospina L, Parra Meza C, Lancheros García EA, Rojas Arias JL, Acuña Osorio E. Prevalencia de malformaciones congénitas diagnosticadas por ultrasonido: tres años de experiencia en una unidad de medicina materno fetal universitaria. Ginecol Obstet México. 2015 [acceso: 13/03/2018];83(11):680-9. Disponible en: http://www.medigraphic.com/pdfs/ginobsmex/gom-2015/gom1511d.pdf4.

  5. Serra Juhe C, Rodríguez Santiago B, Cusco I, Vendrell T, Camats N, Torán N, et al. Contribution of Rare Copy Number Variants to Isolated Human Malformations. PLoS ONE. 2012 [acceso: 13/03/2018];7(10):e45530. PubMed PMID: 23056206. Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.00455305.

  6. Martínez Rubio A, Montes de Oca L, Tissert Tamayo AI, Peña Castillo B, García Fournier G. Diagnóstico prenatal de cardiopatía congénita. Estudio de dos años. Rev Inf Cient. 2016 [acceso: 13/03/2018];95(3):375-85. Disponible en: http://www.medigraphic.com/pdfs/revinfcie/ric-2016/ric163c.pdf6.

  7. Nodarse Rodríguez S, Llanusa Ruiz C, Castillo Sánchez, Sánchez Lombana R, Carrillo Bermúdez L, Peña Abreu R. Marcadores ecográficos del segundo trimestre como indicadores de riesgo de cromosomopatías. Rev Cubana Obstetr Ginecol. 2009 [acceso: 13/03/2018];35(4):85-98. Disponible en: http://scielo.sld.cu/pdf/gin/v35n4/gin10409.pdf7.

  8. Syngelaki A, Hammami A, Bower S, Zidere V, Akolekar R, Nicolaides KH. Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11-13 weeks' gestation. Ultrasound in Obstetric and Gynecology. 2019 [acceso: 11/01/2020];54 (4):468-76. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31408229/8.

  9. Chaix MA, Andelfinger G, Khairy P. Genetic testing in congenital heart disease: A clinical approach. World J Cardiol. 2016 [acceso: 12/01/2018];8(2):180-91. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26981213/9.

  10. Figuinha Milani H, Quindere de Sá Barreto E, da Silveira Ximenes RL, Raimundo Baldo CA, Araujo Júnior E, Moron AF, et al. Malformaciones de la fosa posterior fetal: revisión de los conocimientos actuales. Radiol Bras. 2019;52(6). Disponible en: http://dx.doi.org/10.1590/0100-3984.2018.014110.

  11. Vélez JE, Herrera LE, Arango F, López G. Malformaciones congénitas: correlación, diagnóstico ecográfico y clínico. Rev Colombiana Obstet Ginecol. 2004 [acceso: 13/03/2018];55(3):201-8 Disponible en: http://www.scielo.org.co/pdf/rcog/v55n3/v55n3a04.pdf11.

  12. Tutus S, Ozyurt S, Yilmaz E, Acmaz G, Ali Akin M. North Clin Istanbul. 2014 [acceso: 13/03/2018];1(2):78-83. Disponible en: https://jag.journalagent.com/nci/pdfs/NCI-84803-RESEARCH_ARTICLE-TUTUS.pdf PubMed PMID: 2805830712.

  13. Zaganjor I, Sekkarie A, Tsang BL, Williams J, Razzaghi H, Mulinare J, et al. Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review. PLoS ONE. 2016 [acceso: 13/03/2018];11(4):e0151586. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27064786/ PubMed PMID: 2706478613.

  14. Martínez Rubio A, Montes de Oca L, Tissert Tamayo AI, Peña Castillo B, García Fournier G. Diagnóstico prenatal de cardiopatía congénita. Estudio de dos años. Rev Inf Cient. 2016 [acceso: 13/03/2018];95(3):375-85. Disponible en: http://www.medigraphic.com/pdfs/revinfcie/ric-2016/ric163c.pdf14.

  15. Han Bing MM, Li Ying MM, Tang Yi BA, Qu Xueling MD, Wang Fen BA, Song Haibo BA, et al. Clinical analysis of prenatal ultrasound diagnosis of fetal cardiovascular malformations in the first and second trimesters of pregnancy. Medicine. 2019 [acceso: 11/01/2020];98(33):e16822. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31415400/15.

  16. García Fernández Y, Fernández Ragi RM, Rodríguez Rivero M. Incidencia de las malformaciones congénitas mayores en el recién nacido. Rev Cubana Pediatr. 2006 [acceso: 14/03/2018];78(4). Disponible en: http://scielo.sld.cu/pdf/ped/v78n4/ped03406.pdf16.

  17. Nazer HJ, Cifuentes O L, Ramírez RC. Malformaciones urinarias del Recién Nacido. Estudio ECLAMC 1998-2010. Rev Chilena Pediatr. 2011 [acceso: 14/03/2018];82(6):512-9. Disponible en: https://scielo.conicyt.cl/pdf/rcp/v82n6/art05.pdf17.

  18. García MA, Imbachí L, Hurtado PM, Gracia G, Zarante I. Detección ecográfica de anomalías congénitas en 76.155 nacimientos en Bogotá y Cali, 2011-2012. Biomédica. 2014 [acceso: 13/03/2018];34(3):379-86. Disponible en: http://www.redalyc.org/pdf/843/84331812008.pdf18.

  19. Siegrist Ridruejo J, Bravo Arribas C, Antolín Alvarado E, de León Luis JA, Gámez Aldarete F, Pérez Fernández Pacheco R. Malformaciones esqueléticas: diagnóstico ecográfico y resultados perinatales. Diagnóst Prenat. 2011 [acceso: 14/03/2018];22(1):7-13. Disponible en: http://www.academia.edu/download/50431592/S2173412711000084_S300_es.pdf19.

  20. Postoev VA, Grjibovski AM, Nieboer E, Odland ØJ. Changes in detection of birth defects and perinatal mortality after introduction of prenatal ultrasound screening in the Kola Peninsula (North-West Russia): combination of two birth registries. BMC Pregnancy and Childbirth. 2015 [acceso: 13/03/2018];15:308. PubMed PMID: 26596677. Disponible en: https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-015-0747-120.

  21. Zubair Akbar A. Clinical Significance of Ultrasonography Markers in Prenatal Diagnosis of Turner Syndrome in Fetuses-90 Cases Reports. J Radiol Clin Imaging. 2019;2(1):007-015. DOI: https://doi.org/10.26502/jrci.2644-280900521.

  22. Becker DA, Tang Y, Jacobs AP, Biggio JR, Edwards RK, Subramaniam A. Sensitivity of prenatal ultrasound for detection of trisomy 18. The Journal of Maternal-Fetal Medicine. 2019 [acceso: 11/01/2020];32(22):3716-22. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29712489/22.

  23. Castaño Lam CA, LLambias Peláez A, Espinosa Lazo D. Marcadores ecográficos en la detección del síndrome de Down. Mediciego. 2018;24(1):32-8.

  24. Hurt L, Wright M, Dunstan F, Thomas S, Brook F, Morris S, et al. Prevalence of defined ultrasound findings of unknown significance at the second trimester fetal anomaly scan and their association with adverse pregnancy outcomes: The Welsh study of mothers and babies population-based cohort. Prenat Diagn. 2016 [acceso: 13/03/2018];36(1):40-8. PubMed PMID: 26475362. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26475362/24.

  25. Yanes Calderón M, Mesa Suárez M, Varona Herrera G. Hídrops fetal no inmunológico. Revista Cubana de Obstetricia Ginecología. 2019;45(2):e452.

  26. Ayuso Velasco R, Blesa Sánchez E, Berjano Murga N, Domínguez Arroyo JA, Enríquez Zarabozo EM, Amat Valero S. La ecografía fetal en el segundo trimestre: interés para el cirujano pediatra. Cir Pediatr. 2010 [acceso: 14/03/2018];23(3):173-6. Disponible en: https://www.secipe.org/coldata/upload/revista/2010_23-3_173-176.pdf26.




2020     |     www.medigraphic.com